Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Document Justification for Antipsychotic Use and GDR

Princeton, Illinois Survey Completed on 04-30-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to document an appropriate diagnosis and identify target behaviors to justify the use of an antipsychotic medication for a resident. The resident, who had a diagnosis of vascular dementia with behavioral disturbance, was prescribed Risperidone 0.25 mg at bedtime. The care plan and physician orders referenced the use of Risperidone for behavioral symptoms, but there was no clear documentation of specific target behaviors warranting the medication. Staff interviews confirmed that the resident did not display behaviors such as aggression or harm to self or others, and behavior tracking indicated only two verbal behaviors in the past six months, both occurring before January. The resident's behaviors reportedly improved after moving to a private room, and no recent behaviors were documented that would support ongoing antipsychotic use. Additionally, the facility did not provide appropriate justification for a failed gradual dose reduction (GDR) of Risperidone. The medication was discontinued, but was restarted three days later due to symptoms of insomnia and tearfulness, as documented by the nurse practitioner. However, there was no evidence of a thorough assessment or documentation of behaviors that would necessitate resuming the antipsychotic. The facility's policy requires clear documentation of behaviors, rationale for medication use, and substantiation for unsuccessful GDRs, which was not met in this case.

An unhandled error has occurred. Reload 🗙